Revium Rx
RVRC
$0.50
$0.098924.66%
09/30/2010 | 06/30/2010 | 03/31/2010 | 09/30/2009 | ||
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | -- | -- | -- | |
Cost of Revenue | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | |
SG&A Expenses | 4,955.56% | 24.12% | -96.69% | -97.33% | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 4,955.56% | -16.77% | -99.33% | -99.58% | |
Operating Income | -4,955.56% | -55.63% | 90.78% | -205.88% | |
Income Before Tax | -4,955.56% | -55.63% | 90.78% | -205.88% | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -4,955.56% | -55.63% | 90.78% | -205.88% | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -4,955.56% | -55.63% | 90.78% | -205.88% | |
EBIT | -4,955.56% | -55.63% | 90.78% | -205.88% | |
EBITDA | -- | -- | -- | -- | |
EPS Basic | -3,384.86% | -9.01% | 90.89% | -326.13% | |
Normalized Basic EPS | -3,381.95% | -8.99% | 90.89% | -326.44% | |
EPS Diluted | -3,384.86% | -9.01% | 90.89% | -326.13% | |
Normalized Diluted EPS | -3,381.95% | -8.99% | 90.89% | -326.44% | |
Average Basic Shares Outstanding | 46.41% | 42.83% | 1.16% | -52.98% | |
Average Diluted Shares Outstanding | 46.41% | 42.83% | 1.16% | -52.98% | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |